Compounds > ciprofloxacin

ciprofloxacin and triazoles

ciprofloxacin has been researched along with triazoles in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (16.00)29.6817
2010's20 (80.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Nasr, MN1
Crum-Cianflone, N; Dull, M; Teneza-Mora, N1
Cho, HS; Kang, JI; Kim, DM; Kim, HS; Park, CY1
de Mol, P; Meis, JF1
Kim, DM; Neupane, GP1
Biedenbach, DJ; Castanheira, M; Jones, RN1
Adrian, L; Marco-Urrea, E; Möder, M; Prieto, A; Rodil, R1
Girija, D; Joy Hoskeri, H; Naik, HS; Sharath, N; Sudeep, HV; Vinay Kumar, B1
Kochanek, M; Michels, G; Pfister, R; Shimabukuro-Vornhagen, A1
Bradford, TA; Butler, MS; Cooper, MA; Fry, SR; Huang, JX; Karoli, T; Madala, PK; Mamidyala, SK; Ramu, S; Tee, EH; Zuegg, J1
Cao, TY; Chen, YS; Duan, NN; Hu, GQ; Huang, WL; Wang, GQ; Wang, W; Wen, XY; Xie, SQ; Yin, J1
Brilhante, RS; Caetano, EP; Camargo, ZP; Castelo Branco, DS; Cordeiro, RA; Fechine, MA; Lima, DT; Lima, RA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Rocha, MF; Sidrim, JJ1
Kosikowska, U; Malm, A; Plech, T; Polz-Dacewicz, M; Rajtar, B; Wujec, M1
Chang, CY; Chen, KH; Hou, JY; Huang, TH; Liang, DC; Liu, HC; Yeh, TC1
Endy, TP; Nat, A; Rane, M; Sharma, AM; Sharma, N1
Kaproń, B; Kosikowska, U; Malm, A; Paneth, A; Plech, T; Polz-Dacewicz, M; Rajtar, B; Stączek, P; Strzelczyk, A; Świątek, Ł2
Gao, LZ; Hu, GQ; Huang, WL; Liu, YJ; Ni, LL; Wu, SM; Xie, YS; Yan, Q1
Andrzejczuk, S; Kosikowska, U; Malm, A; Plech, T1
Agarwal, A; Awasthi, SK; Kant, R; Nath, G; Singh, V1
Adamo, A; Beingessner, RL; Briggs, N; Cui, Y; Dai, C; Jamison, TF; Jensen, KF; Kelly, LP; Lin, H; Myerson, AS; O'Mahony, M; Russell, MG; Stelzer, T; Tahara, K; Thomas, DA; Weeranoppanant, N; Zhang, P1
El-Najjar, N; Gessner, A; Hösl, J1
Gao, Y; Guo, HY; Liu, ML; Lü, K; Na, LX; Wang, AP; Xu, Z; Zhang, S1
Abbas, SH; Abd El-Baky, RM; Abdelhafez, EMN; Abuo-Rahma, GEA; Arai, M; Berger, JM; Hauk, G; Mitarai, S; Mohammed, HHH; Moustafa, GAI1
Abbas, SH; Abd El-Hafeez, AA; Abourehab, MAS; Abuo-Rahma, GEA; Alhaj-Suliman, SO; Ebeid, K; Ghosh, P; Hayallah, AM; Mekkawy, AI; Mohammed, HHH; Salem, AK; Wafa, EI1

Other Studies

25 other study(ies) available for ciprofloxacin and triazoles

ArticleYear
Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.
    Archiv der Pharmazie, 2002, Volume: 335, Issue:8

    Topics: Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Microbial Sensitivity Tests; Pyrimidines; Quinoxalines; Triazoles

2002
Black fluid from a traumatic wound.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection

2006
Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction.
    The Journal of infection, 2008, Volume: 57, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Benzoates; Ciprofloxacin; Deferasirox; DNA, Bacterial; Drug Therapy, Combination; Female; Hemochromatosis; Humans; Polymerase Chain Reaction; Sepsis; Triazoles; Vibrio Infections; Vibrio vulnificus

2008
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2009
In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4

    Topics: Anti-Bacterial Agents; Benzoates; Chelating Agents; Ciprofloxacin; Deferasirox; Drug Synergism; Hospitals; Humans; Microbial Sensitivity Tests; Microbial Viability; Republic of Korea; Time Factors; Triazoles; Vibrio Infections; Vibrio vulnificus

2010
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim

2010
Degradation of the antibiotics norfloxacin and ciprofloxacin by a white-rot fungus and identification of degradation products.
    Bioresource technology, 2011, Volume: 102, Issue:23

    Topics: Anti-Bacterial Agents; Biodegradation, Environmental; Biotechnology; Biotransformation; Chromatography, Liquid; Ciprofloxacin; Dimerization; Laccase; Mass Spectrometry; Models, Chemical; Norfloxacin; Oxygen; Tandem Mass Spectrometry; Technology, Pharmaceutical; Time Factors; Trametes; Triazoles

2011
Synthesis and biological evaluation of new Tetra-aza macrocyclic scaffold constrained oxadiazole, thiadiazole and triazole rings.
    Archiv der Pharmazie, 2012, Volume: 345, Issue:3

    Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; Ciprofloxacin; DNA; DNA Replication; Macrocyclic Compounds; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Thiadiazoles; Triazoles

2012
[53-year-old woman with life-threatening complications after use of ciprofloxacin and posaconazol].
    Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:4

    Topics: Anti-Infective Agents; Cardiopulmonary Resuscitation; Ciprofloxacin; Electrocardiography; Female; Humans; Leukemia; Long QT Syndrome; Middle Aged; Risk Factors; Triazoles

2012
Structure aided design of chimeric antibiotics.
    Bioorganic & medicinal chemistry letters, 2012, Apr-01, Volume: 22, Issue:7

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Click Chemistry; Computer Simulation; DNA Gyrase; DNA Topoisomerase IV; Drug Design; Drug Resistance, Microbial; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Topoisomerase II Inhibitors; Triazoles; Trimethoprim

2012
[Part IV. Synthesis and antitumor evaluation of s-triazolothiadiazines and pyrazolo s-triazoles derived from ciproxacin].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2012, Volume: 47, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Ciprofloxacin; Cricetinae; Cricetulus; Fluoroquinolones; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia L1210; Mice; Structure-Activity Relationship; Thiadiazines; Triazoles

2012
Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Antifungal Agents; Caspofungin; Ciprofloxacin; Coccidioides; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Histoplasma; Lipopeptides; Microbial Sensitivity Tests; Mycelium; Pyrimidines; Triazoles; Voriconazole

2013
Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
    European journal of medicinal chemistry, 2013, Volume: 60

    Topics: Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles

2013
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Cancer, 2014, Apr-15, Volume: 120, Issue:8

    Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Costs; Echinocandins; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Voriconazole

2014
Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.
    The American journal of tropical medicine and hygiene, 2014, Volume: 91, Issue:6

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Mycetoma; Triazoles; Young Adult

2014
Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.
    Molecules (Basel, Switzerland), 2015, Apr-09, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triazoles

2015
Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
    European journal of medicinal chemistry, 2015, Jun-05, Volume: 97

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles

2015
[Synthesis and antitumor activity of fluoroquinolon-3-yl-s-triazole sulfide ketones and their derivatives from ciprofloxacin].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2015, Volume: 50, Issue:10

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Ciprofloxacin; Doxorubicin; HL-60 Cells; Humans; Ketones; Sulfides; Triazoles

2015
Inhibitory effect of 1,2,4-triazole-ciprofloxacin hybrids on Haemophilus parainfluenzae and Haemophilus influenzae biofilm formation in vitro under stationary conditions.
    Research in microbiology, 2016, Volume: 167, Issue:8

    Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Haemophilus influenzae; Haemophilus parainfluenzae; Microbial Sensitivity Tests; Microbial Viability; Spectrophotometry; Triazoles

2016
Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
    European journal of medicinal chemistry, 2016, Nov-29, Volume: 124

    Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Ciprofloxacin; Drug Design; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles

2016
Advanced Continuous Flow Platform for On-Demand Pharmaceutical Manufacturing.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2018, Feb-21, Volume: 24, Issue:11

    Topics: Automation; Ciprofloxacin; Neostigmine; Nicardipine; Pharmaceutical Preparations; Triazoles

2018
Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
    Journal of pharmaceutical and biomedical analysis, 2018, Aug-05, Volume: 157

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Limit of Detection; Lipopeptides; Moxifloxacin; Nitriles; Plasma; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles

2018
Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
    Chemistry & biodiversity, 2018, Volume: 15, Issue:10

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Design; Halogenation; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiones; Triazoles

2018
Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.
    Bioorganic chemistry, 2019, Volume: 88

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Triazoles

2019
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization.
    Journal of enzyme inhibition and medicinal chemistry, 2022, Volume: 37, Issue:1

    Topics: Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Ciprofloxacin; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Polymerization; Structure-Activity Relationship; Triazoles; Tubulin

2022